Cardiovascular disease (CVD) is the most common cause of death in NAFLD patients. Liver biopsy and noninvasive markers should be used to stage and grade nonalcoholic steatohepatitis (NASH ...

As mentioned earlier, finding out whether a patient has NASH requires an in-hospital liver biopsy. An NAFLD diagnosis also offers no insights into the etiology of the patient’s disease ...

All you need to know about MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) and how it differs from the ...

NAFLD doesn’t have any physical symptoms, which makes it virtually impossible to identify without blood tests or a liver ...

“Over time, NAFLD can progress to chronic inflammation ... To enroll in the trial, patients needed to have a liver biopsy showing inflammation due to NASH with moderate or advanced liver scarring.

A Cleveland Clinic liver specialist discusses life expectancy with fatty liver disease and provides tips to take charge of your health.

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance and the metabolic syndrome, which are, in turn, associated with obesity. It has been suggested, however ...

The Phase 2b VOYAGE study of VK2809 in patients with biopsy-confirmed non-alcoholic ... of patients with elevated LDL-C and non-alcoholic fatty liver disease (NAFLD). Selective activation of ...

Understanding the link between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular disease is essential. Shared risk factors like obesity and diabetes contribute to both. Pharmaceutical ...